(go to content)

Castellano | Euskara | Français | English

 Imagen decorativa
DTB: Vol 24, No 4

Content tools

Share it

  • Meneame
  • Delicious
  • Twitter
  • Google
  • Facebook

New antidiabetic drugs: What place should they have in therapeutics?

The long-term effectiveness and safety profile of new antidiabetics is still to be established due to the short duration of the trials performed so far. No evidence has been published to demonstrate that new antidiabetics improve the incidence of cardiovascular complications and/or mortality. Metformin is the oral antidiabetic of choice in patients with diabetes mellitus type 2 whose blood glucose levels are not satisfactorily controlled on diet and exercise alone.


  • Mª José Ariz. General Practitioner. Navarre Health Service. Spain
  • Gabriela Elizondo. Head of pharmacovigilance. Health Department. Government of Navarre. Spain
Enviar comentario

You can send us a comment or suggestion and we will respond to most frequently asked questions

Competing interests (complete this field only if you have competing interests)






Government of Navarre

Contact us | Accessibility | Legal notice | Site map